Value Microcaps Motherboard

[cliffvb]

VPHM- Stock down on a disappointing sales and earnings report. Apparently the wholesalers do not want to be stuck with inventory if a generic becomes available soon. VPHM may have more problems down the road. As I recall, they are amortizing the purchase price of their Vancocin over a 25 year period. They said that was warranted because Vancocin is so difficult to replicate even with the expired patents. It seems to me that 25 years is too long a period to expense their purchase, especially in medicine and now with a generic version that apparently is coming as well. "caveat emptor"